Published in J Neural Transm Gen Sect on January 01, 1990
Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berl) (1994) 1.17
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients. Ann Hematol (2005) 1.15
Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol Psychiatry (1999) 1.04
Drugs affecting dopamine neurons and yawning behavior. Pharmacol Biochem Behav (1977) 1.01
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial. Ann Hematol (2004) 0.96
Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J Neurosci (1997) 0.94
Desipramine induces yawning behaviour in rats. Neuropharmacology (1986) 0.93
The behavioural effects of pramipexole, a novel dopamine receptor agonist. Eur J Pharmacol (1997) 0.90
A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist. Behav Pharmacol (2002) 0.89
alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine. J Pharmacol Exp Ther (1999) 0.87
Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning. Neuroscience (2008) 0.87
Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacol (1992) 0.87
Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1990) 0.86
The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol J Pharmacol Pharm (1993) 0.86
Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine. J Physiol Pharmacol (2004) 0.85
Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors. J Neurochem (2006) 0.85
GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids (1998) 0.85
Behavioral pharmacology of sigma-ligands. Pharmacopsychiatry (2004) 0.84
Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci (1979) 0.83
Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands. Pol J Pharmacol (1997) 0.83
The influence of neuroleptics on the behavioural effect of 5-hydroxytryptophan. Pol J Pharmacol Pharm (1979) 0.83
Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology (Berl) (1994) 0.82
Stimulation of food intake following opioid microinjection into the nucleus accumbens septi in rats. Peptides (1987) 0.82
Effects of imidazoline antihypertensive drugs on sympathetic tone and noradrenaline release in the prefrontal cortex. Br J Pharmacol (2001) 0.82
Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression. Brain Res (1999) 0.82
Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. Eur J Pharmacol (1985) 0.81
c-Fos proteins, induced by the serotonin receptor agonist DOI, are not expressed in 5-HT2A positive cortical neurons. Brain Res Mol Brain Res (1999) 0.80
Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity. Eur J Pharmacol (1982) 0.80
NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity. J Neural Transm (Vienna) (1999) 0.80
MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res (1993) 0.79
Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTP. J Pharm Pharmacol (1979) 0.79
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial. Bone Marrow Transplant (2005) 0.79
Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists. Pol J Pharmacol (1996) 0.79
The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain. Psychopharmacology (Berl) (1996) 0.79
Noradrenergic pathology in psychiatric disorders: postmortem studies. CNS Spectr (2001) 0.79
A search for colocalization of mglula receptors with CRF or NPY in the rat brain amygdala. Folia Histochem Cytobiol (2002) 0.79
Synergistic effect of pramipexole and sertraline in the forced swimming test. Pol J Pharmacol (2000) 0.79
Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists. Pol J Pharmacol (1995) 0.79
The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. J Neural Transm (Vienna) (1996) 0.78
Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist. Pol J Pharmacol (1996) 0.78
Effect of tianeptine and fluoxetine on the levels of Met-enkephalin and mRNA encoding proenkephalin in the rat. J Physiol Pharmacol (2002) 0.78
Functional supersensitivity to the alpha 1-adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by beta-down-regulation. Neuropharmacology (1987) 0.78
Adaptive and differential changes on beta- and alpha 2-adrenoreceptors mediated hyperthermia after chronic treatment with antidepressant drugs in the rat kept at high ambient temperature. J Neural Transm (1985) 0.78
Clonidine and a beta-agonists induce hyperthermia in rats at high ambient temperature. J Neural Transm (1985) 0.78
Antidepressant activity of S-adenosyl-L-methionine in mice and rats. J Basic Clin Physiol Pharmacol (1992) 0.78
The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists. J Neural Transm (1979) 0.78
The corticosterone synthesis inhibitor metyrapone decreases dopamine D1 receptors in the rat brain. Neuroscience (1997) 0.78
Effect of chronic administration of antidepressant drugs on the noradrenaline disappearance induced by FLA-63 in the rat brain. Pol J Pharmacol Pharm (1979) 0.78
Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens. Eur J Pharmacol (1987) 0.78
Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems. J Neural Transm (Vienna) (1999) 0.78
Enhancement by ipsapirone of dopamine release in the rat striatum. Pol J Pharmacol (1993) 0.78
5-HT1A receptors mediate detrimental effects of cocaine on long-term potentiation and expression of polysialylated neural cell adhesion molecule protein in rat dentate gyrus. Neuroscience (2009) 0.78
Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. J Neural Transm (Vienna) (1996) 0.78
The effect of (+)- and (-)-oxaprotiline administered repeatedly on the dopamine system. J Neural Transm Gen Sect (1991) 0.77
Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activity. Pol J Pharmacol (1994) 0.77
The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity. Pharmacol Biochem Behav (1984) 0.77
Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain. Eur J Pharmacol (1998) 0.77
The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats. Pol J Pharmacol Pharm (1993) 0.77
Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. Pol J Pharmacol (1998) 0.77
DOI, an agonist of 5-HT2A/2C serotonin receptor, alters the expression of cyclooxygenase-2 in the rat parietal cortex. J Physiol Pharmacol (2002) 0.77
Effect of 1,3-di-o-tolylguanidine (DTG), rimcazole and EMD 57445, the sigma receptor ligands, in the forced swimming test. Pol J Pharmacol (1998) 0.77
The role of dopamine D2 receptor in the behavioral effects of imipramine--study with the use of antisense oligonucleotides. J Physiol Pharmacol (2000) 0.77
Distinct target size of dopamine D-1 and D-2 receptors in rat striatum. Life Sci (1984) 0.77
The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats. J Physiol Pharmacol (2006) 0.77
Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats. Pol J Pharmacol (1998) 0.77
Strain differences in clonidine-induced aggressiveness in mice and its interaction with the dopamine system. Pharmacol Biochem Behav (1993) 0.77
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation. Leukemia (2006) 0.77
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved? J Neural Transm (Vienna) (1999) 0.77
Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens. J Pharm Pharmacol (1985) 0.77
Synergistic effect of amantadine and imipramine in the forced swimming test. Pol J Pharmacol (2001) 0.77
The effect of prolonged administration of lithium on the level of dopamine D2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiol Exp (Wars) (1996) 0.77
MK-801-induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex. Brain Res (1993) 0.76
Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain. Eur J Pharmacol (1996) 0.76
Central effects of repeated treatment with bupropion. Pol J Pharmacol Pharm (1986) 0.76
Cocaine enhances ST8SiaII mRNA expression and neural cell adhesion molecule polysialylation in the rat medial prefrontal cortex. Neuroscience (2011) 0.76
Some behavioural effects of antidepressant drugs are time-dependent. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.76
The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice. Pol J Pharmacol Pharm (1990) 0.76
Metyrapone, an inhibitor of corticosterone synthesis, blocks the kainic acid-induced expression of HSP 70. Synapse (2000) 0.76
Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine. J Pharm Pharmacol (1984) 0.76
Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems. J Neural Transm (Vienna) (2000) 0.76
On the anticataleptic action of cyproheptadine. Pharmacol Biochem Behav (1976) 0.76
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. J Neural Transm Park Dis Dement Sect (1993) 0.76
The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. Neuropharmacology (1992) 0.76
Reserpine-induced locomotor stimulation in mice chronically treated with typical and atypical antidepressants. Eur J Pharmacol (1983) 0.76
Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study. Brain Res Mol Brain Res (2000) 0.76
Effects of REM sleep deprivation on central alpha 1- and beta-adrenoceptors in rat brain. Pharmacol Biochem Behav (1986) 0.76
Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine. J Neural Transm (1984) 0.76
Effects of antihistaminic drugs in tests for antidepressant action. Pol J Pharmacol Pharm (1981) 0.75
[The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia]. Psychiatr Pol (2000) 0.75
Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity. Eur J Pharmacol (1996) 0.75
Neuropsychopharmacological profile of remoxipride in comparison with clozapine. Pol J Pharmacol (1998) 0.75
Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats. J Neural Transm Gen Sect (1991) 0.75
EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine system. Pol J Pharmacol (1998) 0.75
Antidepressant effects of pramipexole, a novel dopamine receptor agonist. J Neural Transm (Vienna) (1997) 0.75
Locomotor hyperactivity induced by MK-801 in rats. Pol J Pharmacol Pharm (1992) 0.75